Connection
Shu-Yi Liao to Cell Line, Tumor
This is a "connection" page, showing publications Shu-Yi Liao has written about Cell Line, Tumor.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.104 |
|
|
|
-
Lei WY, Hsiung SC, Wen SH, Hsieh CH, Chen CL, Wallace CG, Chang CC, Liao SK. Total HLA Class I Antigen Loss with the Downregulation of Antigen-Processing Machinery Components in Two Newly Established Sarcomatoid Hepatocellular Carcinoma Cell Lines. J Immunol Res. 2018; 2018:8363265.
Score: 0.087
-
Wu TS, Wang LC, Liu SC, Hsu TY, Lin CY, Feng GJ, Chen JM, Liu HP, Chung IC, Yen TC, Chang YS, Liao SK, Chang C, Chow KP. EBV oncogene N-LMP1 induces CD4 T cell-mediated angiogenic blockade in the murine tumor model. J Immunol. 2015 May 01; 194(9):4577-87.
Score: 0.017